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everal ganglionic nicotinic acetylcholine receptor
(nAChR) types are abundantly expressed in nonneuronal
locations, but their functions remain unknown. We
found that keratinocyte 
 
 
 
7 nAChR controls homeostasis and
terminal differentiation of epidermal keratinocytes required
for formation of the skin barrier. The effects of functional
inactivation of 
 
 
 
7 nAChR on keratinocyte cell cycle pro-
gression, differentiation, and apoptosis were studied in cell
 
monolayers treated with 
 
 
 
-bungarotoxin or antisense oligo-
nucleotides and in the skin of 
 
Acra7
 
 homozygous mice
lacking 
 
 
 
7 nAChR channels. Elimination of the 
 
 
 
7 signaling
 
pathway blocked nicotine-induced inﬂux of 
 
45
 
Ca
 
2
 
  
 
and
also inhibited terminal differentiation of these cells at the
transcriptional and/or translational level. On the other
S
 
hand, inhibition of the 
 
 
 
7 nAChR pathway favored cell cycle
 
progression. In the epidermis of 
 
 
 
7
 
 
 
/
 
 
 
 mice, the abnormalities
in keratinocyte gene expression were associated with
phenotypic changes characteristic of delayed epidermal
turnover. The lack of 
 
 
 
7 was associated with up-regulated
expression of the 
 
 
 
3 containing nAChR channels that lack
 
 
 
5 subunit, and both homomeric 
 
 
 
9- and heteromeric
 
 
 
9
 
 
 
10-made nAChRs. Thus, this study demonstrates that
ACh signaling through 
 
 
 
7 nAChR channels controls late
stages of keratinocyte development in the epidermis by
regulating expression of the cell cycle progression, apoptosis,
and terminal differentiation genes and that these effects are
mediated, at least in part, by alterations in transmembrane
Ca
 
2
 
 
 
 inﬂux.
 
Introduction
 
Recent progress in the identification of genes encoding new
members of the neuronal nicotinic acetylcholine receptor
(nAChR)* subunit gene superfamily and developing in vivo
models for specific subunit gene deletions has revealed that
the expression of the acetylcholine (ACh)-gated ion channels
is not limited to neurons (Grando, 1997; Lindstrom, 1997).
On the other hand, recent results with receptor subunit
knockout (KO) mice indicated that certain ganglionic
nAChR subtypes are not essential for normal neurological
function (Orr-Urtreger et al., 1997; Paylor et al., 1998).
These unexpected findings suggested that one of the major
biological functions of neuronal-type nAChRs is to subserve
trophic, hormone-like effects of ACh in both neuronal and
nonneuronal locations. Elucidation of the nonneuronal
function of nAChRs, therefore, may lead to better under-
standing of a complex signaling mechanism mediating inter-
actions of the peripheral nervous system with the surrounding
tissues, wherein different cell types use ACh as a common
messenger, or a pacemaker. 
ACh is a ubiquitous chemical in life that, although is best
known for its role in neurotransmission, is produced by
practically all types of live cells and is remarkably abundant
in the epidermis and other types of the surface epithelium
(Grando et al., 1993b; Wessler et al., 1999). It has become
evident that ACh can regulate tissue homeostasis in an auto-
crine and paracrine fashions by exhibiting a plethora of bio-
logical effects on different cell types (Wessler et al., 1998).
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The level of free tissue ACh is controlled by the cholinergic
enzymes choline acetyltransferase and acetylcholinesterase that
are present in nonneuronal cells lining the cutaneous, respira-
tory and alimentary tracts, and blood vessels. In these nonneu-
ronal locations, ACh signaling can be mediated by muscarinic
and nicotinic receptors. Binding of ACh to the cell membrane
receptors elicits several diverse and simultaneous biochemical
events, the “biological sum” of which, together with cumula-
tive effects of other hormonal and environmental stimuli, de-
termines a distinct change in the cell cycle.
The nAChRs are classic representatives of the Cys loop su-
perfamily of ligand-gated ion channel proteins or ionotropic
receptors, mediating the influx of Na
 
 
 
 and Ca
 
2
 
 
 
 and efflux
of K
 
 
 
 (Steinbach, 1990). The differences in subunit compo-
sition of nAChRs determine the functional and pharma-
cological characteristics of the ion channels formed. 12
nAChR subunit genes encoding a pentameric protein have
been identified and designated 
 
 
 
2–
 
 
 
10 and three 
 
 
 
2–
 
 
 
4,
and each subunit has four putative transmembrane-spanning
domains (M1–M4) and a similar topological structure. Each
of 
 
 
 
7, 
 
 
 
8, and 
 
 
 
9 subunits is capable of forming functional
homomeric nAChR channels, which are 
 
 
 
-bungarotoxin
(
 
 
 
-BTX) sensitive. RT-PCR has amplified 
 
 
 
3, 
 
 
 
5, 
 
 
 
7, 
 
 
 
9,
 
 
 
10, 
 
 
 
2, and 
 
 
 
4 subunits from human keratinocytes
(Grando et al., 1995, 1996; Nguyen et al., 2000a, 2001;
Sgard et al., 2002), indicating that keratinocytes express
both heteromeric and homomeric nAChR channels on their
cell membrane. The differences in subunit composition of
nAChRs determine the functional and pharmacological
characteristics of the ion channels formed. 
Current research results indicate that biological effects of
ACh in the skin are finely tuned to regulation of each phase
of the cell cycle via the intracellular signaling pathways cou-
pled by each particular type of nAChRs (Grando, 1997,
2001). In keratinocytes, nAChRs control cell viability, pro-
liferation, differentiation, adhesion, and motility, and con-
stant stimulation of keratinocyte nAChRs with endoge-
nously secreted ACh produced by these cells is essential for
cell survival. We have demonstrated recently that pro-
grammed cell death of keratinocytes culminates in apoptotic
secretion of a humectant upon secretagogue action of ACh
and that activation of ACh signaling through the 
 
 
 
7
nAChR, which is predominantly expressed by mature kera-
tinocytes, is essential for a sustained turnover of the epider-
mis in humans (Nguyen et al., 2001). 
This study was designed to ultimately determine the role
for 
 
 
 
7 nAChR in mediating physiologic control of kerati-
nocyte differentiation by endogenous ACh. Alterations in
the nicotinergic regulation of keratinocyte cycle progression,
differentiation, and apoptosis were investigated in three in-
dependent models of functionally inactivated 
 
 
 
7 nAChR: in
cultured human keratinocytes treated with 
 
 
 
-BTX or anti-
sense oligonucleotides (AsOs) and epidermal keratinocytes
grown from and residing in the skin of KO mice with ho-
mozygous-null mutation of the gene-encoding 
 
 
 
7 nAChR
subunit. We found that pharmacological blockage of 
 
 
 
7
nAChR with 
 
 
 
-BTX inhibits nicotine (Nic)-induced influx
of 
 
45
 
Ca
 
2
 
 
 
 in human keratinocytes, which is associated with
an inhibition of Nic-induced terminal differentiation of
these cells. Functional inactivation of 
 
 
 
7 nAChRs in cul-
 
tured human keratinocytes with AsOs abolished high extra-
cellular Ca
 
2
 
 
 
-induced up-regulated synthesis of the terminal
differentiation proteins. Terminal differentiation gene ex-
pression was found to be down-regulated in the epidermis of
 
 
 
7 KO mice whose keratinocytes demonstrated profound
alterations in the normal cell cycle progression and apoptosis
when grown in culture. The 
 
 
 
7
 
 
 
/
 
 
 
 keratinocytes also dem-
onstrated changes in the gene expression of 
 
 
 
3, 
 
 
 
5, 
 
 
 
9, and
 
 
 
10 nAChR subunits, suggesting that ACh signaling in
these cells is rerouted to alternative nicotinergic pathways.
 
Results
 
The 
 
 
 
-BTX–sensitive component of nicotinergic 
control of keratinocyte differentiation
 
Nicotinergic agents have been demonstrated to affect the rate
of keratinocyte differentiation. It has been shown that Nic ac-
celerates the rate of keratinocyte differentiation which can be
abolished by mecamylamine (Grando et al., 1996), an antago-
nist of the “neuronal” types of the nAChRs expressed in epi-
dermal keratinocytes (Grando et al., 1995). Since kerati-
nocytes express both the heteromeric nAChRs containing 
 
 
 
3
subunit, which are not sensitive to 
 
 
 
-BTX, and the homo-
meric 
 
 
 
7 nAChR, which is highly sensitive to 
 
 
 
-BTX (Levan-
doski et al., 1999), we investigated effects of 
 
 
 
-BTX on the
Nic-induced keratinocyte differentiation in confluent mono-
layers of the second passage human foreskin keratinocytes in-
cubated in the medium containing 0.09 mM Ca
 
2
 
 
 
, in which
both test drugs were dissolved. As seen in Fig. 1, after 14 d of
Figure 1.  -BTX blocks Nic-induced differentiation of human 
keratinocytes. The number of differentiation marker-positive 
keratinocytes (percentage of total cells) after incubation with 10  M 
Nic alone (black bar), 10  M Nic plus 1  M  BTX (hatched bar), or 
without any additions (white bar) (control). The cells were either 
fixed and stained for the differentiation markers cytokeratin 10 
(CK 10), human keratinocyte transglutaminase type I (Trgl), involucrin 
(Invn), or filaggrin (Flgrn) or used in the assay of cornified envelopes 
(CE). Data are means   SD of two independent experiments. In 
each immunocytochemical experiment, the numbers of cells stained 
for a differentiation-associated protein using avidin–biotin complex/
alkaline phosphatase technique (as described in Material and methods) 
were counted in at least three different microscopic fields. 
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exposure to both Nic (10 
 
 
 
M) and 
 
 
 
-BTX (1 
 
 
 
M) the num-
ber of keratinocytes that stained for the differentiation markers
cytokeratin 10, transglutaminase, involucrin, or filaggrin, or
spontaneously formed cornified envelopes was significantly
(P 
 
  
 
0.01) diminished compared with that found in the posi-
tive control cultures exposed to 10 
 
 
 
M Nic alone and did not
significantly differ from the control values (P
 
   
 
0.05). After
shorter incubation periods, i.e., 4, 8, or 10 d, the changes were
less pronounced (unpublished data). The cellular staining pat-
terns produced by antibodies to the differentiation markers
were similar in experimental and control cultures. Thus, the
ability of 
 
 
 
-BTX to abolish Nic-induced differentiation of ke-
ratinocytes indicated that the differentiation-inducing effect of
Nic is predominantly mediated by activation of 
 
 
 
7 nAChR.
 
The 
 
 
 
-BTX–sensitive component of the nicotinergic 
control of transmembrane 
 
45
 
Ca
 
2
 
 
 
 influx in keratinocytes
 
Previously, we have shown that Nic increases 
 
45
 
Ca
 
2
 
 
 
 influx
into keratinocytes freshly dissociated from human epider-
mis, which could be abolished by mecamylamine (Grando et
al., 1996). Using the same cell preparation, we tested the ef-
fects of  -BTX on 
45Ca
2  influx. The presence of  -BTX in
the solution diminished both basal (Fig. 2 A) and Nic (10
 M)-elicited (Fig. 2 B) 
45Ca
2  influx. However, these effects
did not reach significant levels at either of three (0.1, 1.0,
and 10  M)  -BTX concentrations tested (P   0.05). Since
incubation of keratinocytes in the presence of high extracel-
lular Ca
2  up-regulates expression of the gene coding for  7
subunit (Zia et al., 2000), we hypothesized that preincuba-
tion of keratinocytes at high (1.2 mM) Ca
2  before the
45Ca
2  influx assay might increase the sensitivity of Nic-elic-
ited 
45Ca
2  influx to a blockage with  -BTX. As expected, in
pretreated cells  -BTX inhibited 
45Ca
2  influx in a dose-
dependent manner (Fig. 2). To directly address the role of
 7-made nAChR channels in mediating these  -BTX effects,
we measured effects of short (15 min) and long (60 min)
term preincubations at 1.2 mM Ca
2  on the relative amount
of  -BTX binding to the cell membrane of keratinocytes
and total amount of the  7 protein present in these cells, us-
ing ELISA with FITC-labeled  -BTX and Western blot
with rabbit anti- 7 antibody, respectively. We found that a
short term preincubation moderately and a long term prein-
cubation significantly (P   0.05) increased both cell surface
expression of  7 nAChR and total amount of the receptor
protein in the cells (Fig. 2, C and D). Together, these results
indicated that  7-made nicotinic channels may be a major
contributor to transmembrane influx of 
45Ca
2  in epidermal
keratinocytes at increased extracellular Ca
2  levels.
 7 AsOs alters terminal differentiation 
of cultured keratinocytes
Having found that pharmacological inactivation of  7 nAChR
with  -BTX abolishes Nic-induced differentiation, we asked if
elimination of  7-coupled pathway can block terminal differ-
Figure 2. Role of  7 nAChRs in 
mediating spontaneous and Nic-induced 
45Ca
2  influx into human keratinocytes. 
(A and B) Effects of  -BTX on 
transmembrane 
45Ca
2  influx.  -BTX 
decreased in a dose-dependent manner 
both spontaneous (A) and Nic-induced 
(B) influx of 
45Ca
2  into keratinocytes 
freshly isolated from human neonatal 
foreskins. The effects of test concentrations 
of  -BTX on baseline 
45Ca
2  influx were 
measured in cell aliquots suspended in 
KGM without Nic. The inhibitory effects 
of  -BTX on Nic-induced 
45Ca
2  influx 
into keratinocytes were measured in 
aliquots of keratinocyte suspensions in 
KGM containing 10  M Nic. Cell 
aliquots were resuspended in serum-free 
keratinocyte medium (KGM) containing 
either 0.09 (black bar) or 1.2 (white bar) 
mM Ca
2 , incubated for 15 min in a 
humid 5% CO2 incubator, washed, and 
used in the 
45Ca
2  influx assay as 
described in Materials and methods. 
Data are means   SD of representative 
experiments in which triplicate samples 
were measured. The concentrations of 
 -BTX are shown at the bottom of each 
graph. Asterisks indicate that the 
experimental data significantly (P   0.05) 
differ from controls. (C and D) Effects of 
extracellular Ca
2  on expression of  7 nAChR in human keratinocytes. The level of  7 expression on the cell membrane was measured 
using the FITC-labeled  -BTX binding assay detailed in Materials and methods, and the total amount of cellular  7 protein was measured 
by Western blotting using rabbit anti- 7 antibody characterized in the past (Zia et al., 2000). Both 15- and 60-min preincubations increased 
cell surface binding of  -BTX (C). An increase of fluorescence intensity ratio (FIR) became statistically significant after 60 min of incubation 
(P   0.05; denoted with an asterisk). By this point in time, the total amount of  7 protein increased by 32% (D). The  7 band appeared at 
the expected mol wt of 60 kD.328 The Journal of Cell Biology | Volume 159, Number 2, 2002
entiation of keratinocytes. To inhibit  7 expression, we used
phosphorothioated AsOs targeted to mRNA for the  7
nAChR subunit (Table I). In keratinocytes lacking  7
nAChR, terminal differentiation can be induced via a Nic-
independent pathway mediated by other types of Ca
2 -perme-
able ion channels due to increased concentration of extracellu-
lar Ca
2 . Nuclear AsOs uptake of the FITC-tagged AsOs by
keratinocytes was monitored using a fluorescence microscope
(Fig. 3 A). Treatment protocol was optimized to allow maxi-
mal inhibition, i.e.,  80%, as judged from the results of quan-
titative receptor protein analysis by Western blotting (Fig. 3
B). The specificity of antibody binding to the immunoblotting
membranes was confirmed by (a) appearance of  7 protein
band at the expected mol wt (Nguyen et al., 2000a) and (b)
absence of this band in negative control experiments omitting
primary antibody or replacing it with an irrelevant and species-
and isotype-matching antibody (unpublished data).
To determine the effect of inhibited  7 nAChR expres-
sion on the unfolding of the keratinocyte differentiation
program, preconfluent monolayers of human keratinocytes
were fed with serum-free keratinocyte growth medium
(KGM) containing a differentiation-inducing concentration
of Ca
2 , 1.2 mM, and incubated in a humid 5% CO2 incu-
bator at 37 C for 96 h in the presence (experiment) or ab-
sence (baseline) of a mixture of five phosphorothioated anti-
 7 AsOs or the same concentration of sense oligonucleotide
used as a negative control for AsOs (Table I). After incuba-
tion, relative amounts of differentiation marker proteins
were measured in experimental and control cells and com-
pared. As seen in Fig. 3 C, functional deletion of  7 nAChR
Table I. Oligodeoxynucleotides (ODNs) used in this study
ODN Sequence Function
 7.1 5 -(F
a)CGTAAGACCAGGACCAAACTTCAG-3  Fluorescein ODN  7 antisense
 7.2 5 -C
bGAGCAGCATGAAGACGGTAA
bG-3  Phosphorothioated  7 antisense
 7.3 5 -G
bGTCCAGAACTACAATCCCT
bT-3  Phosphorothioated  7 antisense
 7.4 5 -C
bCAATGACTCGCAACCACTCA
bC-3  Phosphorothioated  7 antisense
 7.5 5 -T
bCATGGACGTGGATGAGAAGAA
bC-3  Phosphorothioated  7 antisense
 7.6 5 -G
bACGCCACATTCCACACTAAC
bG-3  Phosphorothioated  7 antisense
 7.6 5 -C
bTGCGGTGTAAGGTGTGATTG
bC-3  Phosphorothioated  7 sense
aFluorescein.
bPhosphorothioate.
Figure 3. Anti- 7 AsOs prevents high extracellular 
Ca
2 -induced terminal differentiation of human 
keratinocytes. (A) Intracellular accumulation of FITC-
labeled  7 AsOs. FITC-labeled AsOs (Table I), 20 nM, 
was added to the second passage human keratinocytes. 
Localized FITC-labeled AsOs was viewed live via 
phase–contrast fluorescence microscopy after a 24-h 
incubation ( 400). Note that anti- 7 AsOs is distributed 
into the nucleus and the cytoplasm. Control oligo-
nucleotide was similarly distributed (unpublished 
data). (B) Effect of anti- 7 AsOs on the  7 nAChR 
subunit protein in human keratinocytes. The cells 
were seeded in 24-well plates at a density of 5 x 10
4/well 
and incubated in a 5% CO2 incubator for 72 h in 
KGM in the presence of Lipofectamine Plus™ alone 
(control), 20 nM of sense oligonucleotide, or 20 nM of 
each of five phosphorothioated AsOs (Table I). The 
anti- 7 AsOs dramatically reduced the intensity of the 
60-kD receptor band in the immunoblot. Control 
(i.e., sense) oligonucleotide did not alter the total 
amount of  7 protein. (C) Alterations in the expression 
of differentiation markers in keratinocytes treated with 
anti- 7 AsOs. Relative amounts of filaggrin, loricrin, 
and cytokeratins (CK) 1 and 10 were analyzed by 
Western blotting of the total protein isolated from 
human keratinocytes transfected with anti- 7 AsOs or 
the control oligonucleotide described above, or intact 
keratinocytes after 96 h incubation of these cells in 
KGM containing 1.2 mM Ca
2 , to induce terminal 
differentiation. Nonneuronal function of  7 nicotinic receptor | Arredondo et al. 329
resulted in characteristic changes in the differentiation gene
expression. We found an  50% decrease of the levels of fil-
aggrin, loricrin, and cytokeratins 1 and 10, compared with
the levels found in control, nonexposed cells. This effect of
anti- 7 AsOs markedly differed from that of the control
(sense) oligonucleotide, which produced only minor fluctua-
tions of the protein levels of the differentiation markers un-
der consideration (Fig. 3 C). Thus,  7 AsOs-treated kerati-
nocytes showed resistance to Ca
2 -induced cornification.
These results indicated that inactivation of the  7 nAChR-
coupled pathway of ACh signaling interferes with terminal
differentiation of human keratinocytes.
Abnormal keratinocyte differentiation 
in the skin of  7 KO mice
To correlate changes in the cell cycle and differentiation gene
expression resulting from inactivation of  7 nAChR-coupled
signaling pathways in vitro with the in vivo phenotype caused
by the absence  7 nAChR channels in the epidermis, we stud-
ied pups delivered by  7
 /  mice, followed by genotyping (Fig.
4 A). Compared with wild-type  7
 /  mice aged from 1 to 3
wk, whose epidermis usually consists of one to two rows of live
nucleated keratinocytes and a compact horny layer comprised
of dead corneocytes (Fig. 4 B),  7
 /  mice featured thickened,
multilayered epidermis (Fig. 4 C). In addition to the lowermost
basal layer, the epidermis in  7
 /  mice contained an addi-
tional two to three suprabasilar rows of pale and enlarged kera-
tinocytes and from one to three rows of granular keratinocytes
located just below widened and loose horny layer. Thus, the
phenotypic abnormalities in the epidermis of  7 KO mice were
consistent with retention hyperkeratosis, which is a morpho-
logic manifestation of delayed epidermal turnover. 
To relate changes in the skin development of  7 KO mice
to  7 nAChR-mediated control of keratinocyte cell cycle
Figure 4. Reduced rate of keratinocyte 
cornification in the epidermis of  7 KO 
mice. (A) Representative PCR profiles of 
the homozygous and heterozygous mice 
from a progeny of a heterozygous  7
 /  
mouse. Genomic DNA was extracted by 
a standard digestion method (Orr-Urtreger 
et al., 1997). The PCR primers were 
generated for intronic regions flanking 
exon 8 and 10 and used in experiments 
at the following concentrations: P1 
(wild-type forward), CCTGGTCCTGCT-
GTGTTAAACTGCTTC (20 pmol); P2 
(wild-type reverse), CTGCTGGGAAATC-
CTAGGCACACTTGAG (10 pmol); and 
P3 (KO), GACAAGACCGGCTTCCATC-
CGAGTAC (25 pmol). DMSO (1:20) was 
included in PCR reactions, and the 
annealing temperature was 56 C. The 
size of the gene product amplified from a 
wild-type mouse was 440 bp and that 
from  7
 /  mouse was 750 bp. The PCR 
analysis identifies the  7 homozygous-null 
( / ) and wild-type ( / ) animals and 
the heterozygous ( / ) mouse. (B and C) 
Comparative histology of the skin of  7
 /  
(B) and  7
 /  (C) mice. The epidermis of 
wild-type mouse is comprised of basal 
keratinocytes attached to the epidermal 
basal membrane and a single suprabasal 
cell layer. In marked contrast, the 
epidermis of  7
 /  mouse, in addition to 
the basal layer, consists of several rows of suprabasal keratinocytes, including a superficially located layer of granular keratinocytes, and the 
uppermost stratum corneum, which is unusually loose and thick. Light microscopy of the hematoxylin and eosin stained 6- m-thick cryostat 
sections of skin obtained from heads of 3-d-old  7
 /  and  7
 /  mice. Magnification,  200. Bar, 25  m. (D) Analysis of the expression of 
keratinocyte differentiation proteins cytokeratin (CK) 1, CK 10, and filaggrin by RT-PCR. The mRNA levels of the keratinocyte differentiation 
markers were determined using specific PCR primers (Table II) and cDNA template from the skin of neonatal  7 KO and wild-type mice as 
described in Materials and methods. Amplification yielded PCR products of the expected sizes: 534 bp for filaggrin, 461 bp for CK 1, and 364 bp 
for CK 10. Amplification of the GAPDH gene product (354 bp) was used to normalize the cDNA content in each sample and as a positive 
control for RT-PCR effectiveness. (E) Analysis of the expression of keratinocyte differentiation proteins CK 1 and 10 and filaggrin by Western 
blotting. These markers of terminal differentiation were visualized at the expected mol wt (shown in kD on the left side of the gels) in the 15% 
SDS-PAGE–resolved proteins, 10  g per lane, extracted from the skin of  7 KO and wild-type mice using specific antibodies, and all appropriate 
negative controls. (F) Semiquantitative IF analysis of relative amounts of differentiation markers in the epidermis of  7 KO and wild-type 
neonatal mice. The cryostat sections of the skin from killed mice were stained with antibodies specific for the keratohyalin granule proteins 
filaggrin (Flgrn), and loricrin (Lrcn), and the CK proteins 1 and 6 (Table III), and the relative amounts of these keratinocyte proteins in the 
epidermis of  7
 /  (black bar) and  7
 /  (white bar) mice were determined using computer-assisted analyses of the specific IF tissue staining as 
detailed in the Materials and methods section. The assay revealed that although the expression of filaggrin, loricrin, and CK 1 was significantly 
decreased, that of CK 6 was significantly increased in  7
 /  compared with  7
 /  mice (P   0.05).330 The Journal of Cell Biology | Volume 159, Number 2, 2002
and differentiation, we performed quantitative analysis of
mRNA and protein levels of the genes encoding keratinocyte
differentiation markers in  7 KO compared with wild-type
 7
 /  mice. Gene-specific primers for murine filaggrin and
cytokeratins 1 and 10 (Table II) amplified products of the
expected sizes (Fig. 4 D). The Acra7 homozygous mutant
mice showed decreased mRNA levels of all three terminal
differentiation markers, ranging from 36 to 54%. The glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) gene am-
plification remained constant in each experiment (Fig. 4 D). 
Findings of down-regulated expression of terminal differ-
entiation genes in keratinocytes residing in the epidermis of
 7
 /  mice were corroborated by results of the Western blot
assay (Fig. 4 E). The  7 deletion was associated with the de-
crease of the filaggrin and cytokeratin 1 and 10 proteins. 
To ultimately determine changes in the differentiation
proteins in epidermis of  7 KO mice, we measured the rela-
tive intensities of specific staining of keratinocytes produced
by antibodies against the keratohyaline proteins filaggrin
and loricrin and the intermediate filament proteins cytoker-
atin 1 and 6, using semiquantitative immunofluorescence
(IF) assay. We found that in the epidermis of  7
 /  mice,
the abundance of terminally differentiated keratinocytes ex-
pressing filaggrin, loricrin, and cytokeratin 1 was signifi-
cantly (P   0.05) less than that in the epidermis of  7
 / 
mice (Fig. 4 F). In marked contrast, the intensity of epider-
mal staining for cytokeratin 6, a marker of rapidly proliferat-
ing, immature keratinocytes (Foley et al., 1998; Gibbs et al.,
2000), was significantly increased (P   0.05), which is con-
sistent with the appearance of the prolonged epidermal turn-
over phenotype in  7
 /  mice.
Abnormalities in cell cycle regulation 
of  7 KO keratinocytes
When cell cycle and apoptosis gene expression in  7
 /  ke-
ratinocytes was analyzed by RT-PCR, we found that Ki-67,
cyclin D1, and PCNA were increased by 52, 77, and 52%,
respectively, compared with  7
 /  cells (Fig. 5 A). The
mRNA level of p53 also increased by 54%. By immunoblot-
ting, we found that the relative amount of Ki-67, cyclin D1,
PCNA, and p53 were increased in  7
 /  keratinocytes (Fig.
5 B). On the other hand, the mRNA and protein levels of
caspase-3 decreased 24 and 57%, respectively, whereas those
of Bcl-2 both increased (Fig. 5). 
The results of the semiquantitative IF assay confirmed the
above findings (Fig. 5 C). As expected from the results of
RT-PCR and immunoblotting assays, we found significant
(P   0.05) increases of the relative amounts of keratinocyte
Ki-67, PCNA, cyclin D1, and p53 and a decrease of caspase
3 in keratinocytes residing in the epidermis of  7 KO mice
compared with the epidermis of wild-type mice. These re-
sults suggested that in the absence of  7 nAChR, the nic-
otinergic pathway of autocrine and paracrine control of
keratinocyte growth and differentiation is predominantly
mediated by other type(s) of ACh-gated ion channels that
are coupled to maintenance of the immature cell phenotype.
Altered expressions of nicotinic receptor subunits 
in  7 KO keratinocytes
To test a hypothesis that mutational deletion of Acra7 in ke-
ratinocytes evokes changes in the relative amounts of differ-
ent nAChR channels, we investigated expression of the genes
coding for  3,  5,  9, and  10 subunits in  7
 /  versus
 7
 /  keratinocytes. By RT-PCR, we found that the expres-
sion of the gene coding for  3 in  7
 /  keratinocytes was
up-regulated by 56%, whereas that of  5 was apparently un-
changed (Fig. 6 A). Results of the Western blotting assay
showed an 86% increase of the relative amount of  3 protein
in  7
 /  keratinocytes (Fig. 6 B). The protein level of  5 was
found to be unchanged. These results indicated that although
the total number of  3 containing nAChR increases in the
epidermis of  7 KO mice, the proportion of the  3 nAChRs
containing  5 subunit is actually less then in wild-type mice.
The relative amounts of both mRNA and proteins of  9 and
Table II. Murine genes studied by RT-PCR
Common name Abbreviation Gene name Accession no.
a Primers
Glyceraldehyde-3-phosphate dehydrogenase Gapdh Gapd M17701 214–234, 401–449
nAChRs
Subunit  3  3 Chrna3 XO3440 434–455, 895–918
Subunit  5  5 Chrna5 AF204689 788–801, 1,238–1,257
Subunit  7  7 Chrna7 AF225980 555–575, 1,027–1,048
Subunit  9  9 Chrna9 AK010496 385–406, 821–842
Subunit  10  10 Chrna10 NM022639 340–358, 720–742
Cell cycle markers
p53-dependent G2 arrest p53 Reprimo AB043586 94–118, 463–482
Proliferation-related Ki-67antigen Ki-67 Mki67 X82786 1,091–1,113, 1,570–1,589
Proliferation cell nuclear antigen PCNA Pcna X57800 131–150, 437–415
Cyclin D1 Cyl 1 Ccnd1 M64403 339–369, 797–820
Cell differentiation markers
Cytokeratin 1 CK1 Krt1 M27734 307–330, 744–767
Cytokeratin 10 CK10 Krt10 V00830 202–225, 665–642
Filaggrin Flg J03458 278–298, 588–609
Cell apoptosis markers
Bcl-2, apoptosis inhibitor Bcl-2 Bcl2 L31532 376–399, 730–751
Caspase 3, apoptosis-related cysteine protease CPP32 Casp3 U54801 225–246, 657–676
aSequence data available from GenBank/EMBL/DDBJ. Nonneuronal function of  7 nicotinic receptor | Arredondo et al. 331
 10 subunits were elevated in  7
 /  keratinocytes (Fig. 6).
However, an increase of the protein level of  9 by 63% ex-
ceeded that of  10 subunit, indicating that both the hetero-
meric  9 10 and the homomeric  9-made ACh-gated ion
channels were up-regulated in  7
 /  keratinocytes.
Discussion
This study provides several lines of evidence that the  7
nAChR-mediated signaling is critical for normal epidermal
differentiation. We used three independent approaches to in-
hibit this nicotinergic pathway of ACh signaling in kerati-
nocytes and consistently identified reciprocal changes in the
expression of the cell cycle progression and differentiation
regulators. The keratinocytes treated with  -BTX or a mix-
ture of phosphorothioated AsOs targeted to mRNA for the
 7 nAChR subunit, and the Acra7 homozygous mice lacking
 7 nAChR channels, all demonstrated considerable down-
regulation of terminal differentiation gene expression at the
transcriptional and/or translational levels. On the other
hand, inhibition of the  7 nAChR pathway favored expres-
sion of the cell cycle progression regulators stimulating cell
growth and decreased expression of the proapoptotic caspase
3. The  7 nAChR-related changes in the cell cycle and dif-
ferentiation caused a transient delay in skin development ob-
served in  7 KO mice during the first 3 wk of their lives.
These alterations in the genetically determined unfolding of
the keratinocyte differentiation program in  7 KO mice and
phenotypic abnormalities consistent with delayed epidermal
turnover were associated with changes in the repertoire of ke-
ratinocyte nAChR subtypes, suggesting that the nicotinergic
pathways dominating in the  7
 /  keratinocytes are coupled
to maintenance of the immature cell phenotype. 
Findings of the new and important biological function of
“neuronal”  7 nAChR in a nonneuronal location such as the
physiologic control of homeostasis and terminal differentia-
tion of the stratified squamous epithelium was anticipated
based on the following reasons. First, despite multiple mor-
phological, biochemical, and electrophysiological studies, the
functions of neuronal  -BTX binding sites in the mamma-
lian brain remain largely unknown. Furthermore, a mutation
deleting the last three exons of the gene for the  7 nAChR
subunit that completely eliminates its potential for participa-
tion in an ion channel does not alter normal general appear-
ance, growth, survival, gait, anatomy, and baseline behavioral
responses (Orr-Urtreger et al., 1997; Paylor et al., 1998).
Thus, although the Acra7 homozygous mutant mice demon-
strated that the  7 subunit is not essential for normal devel-
Figure 5. Alterations in the cell cycle and apoptosis 
gene expression in  7 KO keratinocytes. (A) Analysis of 
the expression of keratinocyte cell cycle and apoptosis 
regulatory genes by RT-PCR. Total RNA was isolated 
from the second passage,  75% confluent monolayers 
of neonatal  7 homozygous-null ( / ) and wild-type 
( / ) keratinocytes and used in the RT-PCR assays 
described in Materials and methods. Gene-specific 
RT-PCR primers were designed to amplify the murine 
cell cycle regulation genes coding for p53, Ki-67, 
cyclin D1, and PCNA, antiapoptotic Bcl-2, and the 
cell apoptosis marker gene caspase 3 (Table II). Each 
primer set yielded PCR product of expected size: 499 
bp for Ki-67, 482 bp for cyclin D1, 307 bp for PCNA, 
389 bp for p53, 376 bp for Bcl-2, and 494 bp for 
caspase 3. (B) Analysis of the expression of keratinocyte 
cell cycle and apoptosis regulatory genes by Western 
blotting. Total protein was isolated from the same cells 
as in A and used in the Western blotting assay 
described in Materials and methods. The mol wt of 
each protein is shown in kD to the right of the gels. 
Each protein band was visualized at the expected mol 
wt. Changes in the gene expression of each of the cell 
cycle and apoptosis markers detectable by Western 
blots were consistent with those determined by RT-PCR. 
(C) Semiquantitative IF analysis of relative amounts of 
keratinocyte cell cycle and apoptosis markers in the 
epidermis of  7 KO and wild-type neonatal mice. The 
cryostat sections of skin from killed mice were stained 
with antibodies specific for the cell cycle progression 
regulators Ki-67, PCNA, cyclin D1 (CyD1), and p53, 
and the marker of cell apoptosis caspase 3 (Cs3) 
(Table III), and the relative amounts of these keratinocyte 
proteins in the epidermis of  7
 /  (black bar) and  7
 /  
(white bar) mice were computed based on the relative 
intensity of specific IF staining as detailed in Materials 
and methods.332 The Journal of Cell Biology | Volume 159, Number 2, 2002
opment or for apparently normal neurological function, they
proved to have phenotypic abnormalities in the epidermis,
thus providing a valuable tool for defining the functional role
of the keratinocyte  7 nAChR channel in the epidermis. 
Second, in addition to modulation of neurotransmitter re-
lease the  7 nAChR has been implicated in regulating neu-
ronal growth and differentiation via a large variety of ge-
nomic and nongenomic effects, including the promotion of
neuronal proliferation (Quik et al., 1994; Plummer et al.,
2000), neuroprotection (Gueorguiev et al., 2000; Li et al.,
2000; Garrido et al., 2001), and induction of apoptosis
(Renshaw et al., 1993; Hory-Lee and Frank, 1995; Berger et
al., 1998). Neuronal  7 nAChR acts through different intra-
cellular transduction pathways to protect or kill cells (Li et
al., 1999). It has been proposed that  7 nAChR helps regu-
late neuronal development by modulating intracellular Ca
2 
levels and thus affecting neuronal differentiation and synap-
togenesis (Broide and Leslie, 1999). The genomic effects
downstream of  7 nAChR are represented by activation of
tyrosine hydroxylase and dopamine  -hydroxylase gene ex-
pression in PC12 cells (Gueorguiev et al., 2000), whereas the
nongenomic pathways involve regulation of protein phos-
phorylation (Schuller et al., 2000; Kihara et al., 2001). 
Third, the  7 subunit is abundantly expressed in the epi-
thelial cells lining skin, oral mucosa, esophagus, trachea, and
bronchi, in which nicotinergic stimulation alters cellular me-
tabolism of Ca
2  (Grando et al., 1996; Zia et al., 1997;
Nguyen et al., 2000a), endothelial cells (Wang et al., 2001),
and in cells surrounding large airways and blood vessels, al-
veolar type II cells, free alveolar macrophages, and pulmo-
nary neuroendocrine cells (Sekhon et al., 1999). In the
mammalian fetal lung,  7 nAChR may regulate neuropep-
tide release, collagen expression, and ultimately lung devel-
opment (Sekhon et al., 1999). The expression of  7 nAChR
channels on the cell membrane of nonneuronal cells is mod-
ulated by exposure to Nic (Zia et al., 1997; Arredondo et al.,
2001), which may provide a mechanism for Nic-induced
changes in gene expression (Arredondo et al., 2001; Zhang
et al., 2001a,b), proliferation (Waggoner and Wang, 1994;
Stone et al., 2001), apoptosis (LeSage et al., 1999; Heeschen
et al., 2001), secretion (LeSage et al., 1999), and tumor
growth (Heeschen et al., 2001) in nonneuronal locations. 
The contribution of different nAChR subunits to forma-
tion of ACh-gated nicotinic ion channels in the plasma mem-
brane of keratinocytes changes with keratinocyte maturation
(Zia et al., 2000). Antibody mapping studies in human epi-
dermis have shown that the bulk of  7 immunoreactivity is
localized to the cell membranes of mature keratinocytes com-
prising the granular layer (Nguyen et al., 2001). In kerati-
nocyte cultures, the abundant expression of  7 was observed
on the cell membrane of mature cells, which required prein-
cubation of cultures in KGM containing a differentiation-
inducing concentration of Ca
2  or Nic (Zia et al., 2000). In
contrast, the  3-containing nAChRs are present at the earli-
est stages of keratinocyte development (Nguyen et al., 2000a;
Zia et al., 2000). Extracellular Ca
2  has been shown to regu-
late responses of both  3- and  7-containing nAChRs on
chick ciliary ganglion neurons (Liu and Berg, 1999). Al-
Figure 6. Alterations in the  3,  5,  9, and  10 
nAChR subunit gene expression in  7 KO keratinocytes. 
(A) The levels of  3,  5,  9, and  10 nAChR subunit 
gene transcription in  7
 /  keratinocytes. The detection 
of the nAChR subunit transcripts by RT-PCR was 
performed using gene specific primers for the murine 
 3,  5,  9, and  10 nAChR subunits (Table II) and 
cDNA from the second passage,  75% confluent 
monolayers of neonatal  7 homozygous null ( / ) 
and wild-type ( / ) mice as template. Each pair of 
primers yielded a PCR product of the expected size: 
485 bp for  3, 480 bp for  5, 458 bp for  9, and 463 
bp for  10. (B) The levels of  3,  5,  9, and  10 
nAChR subunit gene translation in  7
 /  keratinocytes. 
The nAChR subunit proteins were visualized by Western 
blots of total proteins extracted from the same cells as 
in A. Results of a representative experiment showing 
protein bands recognized by rabbit polyclonal 
antibodies specific for  3,  5,  9, or  10 (Table III) 
resolved on 15% SDS-PAGE and immunoblotted as 
described in Materials and methods. The apparent 
mol wt of each receptor protein is shown in kD at the 
right side of the gel. Nonneuronal function of  7 nicotinic receptor | Arredondo et al. 333
though both  3 and  7 subunits can contribute to the
nAChRs that are permeable to Ca
2 , the ACh-gated ion
channels composed of the  7 subunits have the greatest Ca
2 
permeability (Seguela et al., 1993). The results of this study
demonstrated that the need to preincubate keratinocytes at
differentiation-inducing concentrations of extracellular Ca
2 
in order to increase the sensitivity of their response to Nic to
a blockage with  -BTX in the 
45Ca
2  influx assay is explained
by up-regulated expression of  7 nAChRs. 
Results of this study demonstrate that ACh signaling
through  7 nAChR channels controls the maturation and
the cornification stages of keratinocyte development in the
epidermis. Downstream signaling from  7 nAChR regulates
expression of cell cycle progression, apoptosis, and terminal
differentiation regulators at the transcriptional and/or trans-
lational levels. These effects may be mediated, at least in
part, by changes in Ca
2  metabolism. A “gain of function”
mutation of the ACh-gated ion channels comprised by  7
subunits demonstrated that neurons expressing only mutant
nAChRs are susceptible to abnormal apoptosis and degener-
ation, possibly due to increased Ca
2  influx (Treinin and
Chalfie, 1995; Orr-Urtreger et al., 2000; Broide et al.,
2001). We found that neither  -BTX could completely
block Nic-induced differential of keratinocytes nor anti- 7
AsOs could completely abolish the process of cornification
elicited by increasing the concentration of extracellular Ca
2 
in KGM. Instead of using Nic to induce keratinocytes dif-
ferentiation as in experiments with  -BTX, the differentia-
tion of anti- 7 AsOs-treated keratinocytes was induced
through alternative pathway(s) sensitive to high extracellular
Ca
2 , since in these cells the  7 nAChR pathway was inacti-
vated due to treatment with anti- 7 AsOs. These findings
suggest that the  7 nAChR-mediated pathway works to-
gether with other cholinergic and noncholinergic signaling
pathways to sustain a constant advancement of a kerati-
nocyte through its differentiation stages toward its pro-
grammed death. In acute experiments, such as treatment of
cells with  -BTX or anti- 7 AsOs, the alternative pathway
apparently could not get engaged fast enough to compensate
for the missing function, which is illustrated by an approxi-
mately fivefold drop in the number of cells capable of spon-
taneous cornified envelope formation (Fig. 1). In marked
contrast, in the epidermis of  7 KO mice the process of
cornification, although delayed, proceeds via a normal path,
surfacing skin of these mice with an impermeable barrier or
the stratum corneum. Therefore, a lesser magnitude of
changes of the gene expression in keratinocytes residing in
the epidermis of  7 KO mice (Fig. 4 E) compared with ke-
ratinocytes treated with anti- 7 AsOs (Fig. 3 C), as judged
from the results of the Western blotting assay, may be ex-
plained by putative physiologic backup mechanisms acti-
vated during the development of a KO mouse but lacking in
the cells treated with AsOs in which the  7 AChRs are inac-
tivated acutely at the posttranscriptional level. 
To test a hypothesis that mutational deletion of  7 brings
about changes in the repertoire of nAChR channels, we de-
termined the ratios of different   subunit gene expression in
 7
 /  keratinocytes. We found alterations in the expression
of  3,  9, and  10 nAChRs subunits, indicating that the
nicotinergic signaling in the skin of  7 KO mice is predom-
inantly mediated via a nAChR complex containing  3 with-
out  5 and both homomeric  9- and heteromeric  9 10-
made nAChRs. This switch in subunit composition of the
nAChR-gated ion channels may, in turn, bring about a cor-
responding switch in the ionic properties of the ion channels
formed because of shifting of the nicotinergic signaling to
the nAChRs that differ in subunit composition, pharmacol-
ogy, conductance, and kinetics and in their permeability to
and modulation by Ca
2 . For instance, it has been shown
that  5 subunit increases Ca
2  permeability of  3 nAChR
so that the Ca
2  permeability of  3 2 5 nAChRs is compa-
rable to that of  7 nAChRs (Gerzanich et al., 1998). Hence,
a relative decrease of the proportion of  3 nAChRs contain-
ing  5 subunits, i.e.,  3 2 5, in  7
 /  keratinocytes can
bring about corresponding changes in the ionic properties of
the channel, leading to a complex changes in cell cycle regu-
lation, including proliferation-inducing effects, DNA repair
and replication anomalies, and antiapoptotic gene activa-
tion. On the other hand, up-regulated expression of  9-con-
taining nAChRs that mediate proapoptotic action of ACh at
the granular cell–corneocyte transition, which culminates in
programmed cell death within the epidermis (Nguyen et al.,
2001), may compensate for a lacking component of the nic-
otinergic control of terminal differentiation of  7
 /  kerati-
nocytes, allowing formation of the functional epidermal bar-
rier in  7 KO mice. The nAChR incorporating  9 subunits
represents a novel ionotropic and metabotropic receptor/
Ca
2  channel (Elgoyhen et al., 1994; Glowatzki et al., 1995;
Wikstrom et al., 1998). Compared with homomeric  9
channels, the  9 10 nAChR channel displays faster and
more extensive agonist-mediated desensitization, a distinct
current-voltage relationship, and a biphasic response to
changes in extracellular Ca
2  ions (Elgoyhen et al., 2001).
Thus, although the use of KO mice is probably the most
straightforward and rewarding approach to dissect biological
function of each particular type of keratinocyte nAChRs,
providing an unambiguous mechanistic insight into differ-
ential control of keratinocyte functions by ACh, the missing
function may be partially compensated or obscured due to
engagement of the alternative regulatory pathways. 
In conclusion, the comprehensive analysis of the biological
role of  7 nAChR in keratinocytes revealed its important
role in sustaining normal unfolding of the genetically deter-
mined program of cell differentiation eventuating in cell
death, or cornification, which is required for formation of
the skin barrier. The ACh signaling through  7-made chan-
nels may evoke rapid and profound changes in the cellular
metabolism of free Ca
2  due to modulation of its transmem-
brane flux. The downstream signaling apparently harbor
both genomic and nongenomic effects, the biologic sum
of which determines the rate of keratinocyte progression
through the differential steps. In Acra7 homozygous mu-
tant mice, the missing regulatory pathway causes transient
changes in skin phenotype characteristic of delayed epider-
mal turnover. The changes are partially compensated due to
redirection of the nicotinergic signaling via the  3-type kera-
tinocyte nAChRs that in the past were found to be associated
with immature cell phenotype (Zia et al., 2000), and the  9-
type keratinocyte nAChRs that are coupled to regulation of
keratinocyte apoptotic secretion (Nguyen et al., 2001).334 The Journal of Cell Biology | Volume 159, Number 2, 2002
Materials and methods
Human keratinocyte culture experiments
Human keratinocyte cultures were started from normal neonatal foreskins
as we described in detail earlier (Grando et al., 1993a). The cells were
grown in 75-cm
2 flasks (Corning Glass Works) in KGM containing 0.09
mM Ca
2  (GIBCO BRL) at 37 C in a humid 5% CO2 incubator. To study
nicotinergic effect on cell differentiation, keratinocytes were seeded into
6-well tissue culture plates (Falcon 3046; Becton Dickinson) at a cell den-
sity of 10
5/well, grown to  75% confluence in 2 ml of KGM containing
0.09 mM Ca
2 , after which the monolayers received KGM containing 10
 M Nic, 10  M Nic plus 1  M  -BTX (both from Sigma-Aldrich), or no
additions (control), and the incubation was continued for additional peri-
ods of time (as described in Results) with replacing KGM every other day.
After incubation, the monolayers were washed with prewarmed Ca
2 - and
Mg
2 -free PBS (GIBCO BRL) and used either in immunocytochemical as-
say of differentiation marker expression (see below) or in a modification of
the spontaneous cornified envelope formation assay (Rice and Green,
1979) as described in detail elsewhere (Grando et al., 1996).
 7 KO mice and murine keratinocyte cultures
The  7 KO mice used in experiments were Acra7-deficient ( 7 null) mice
generated as described previously (Orr-Urtreger et al., 1997). All control
mice were  7
 /  littermates of  7
 /  mice. The animals were killed, and
skin samples were collected. The samples destined to RNA and protein ex-
tractions were fresh-frozen in liquid nitrogen or freshly embedded in the
OCT Tissue Tek compound (Sakura) for use in IF experiments. All of the
experiments were conducted by an experimenter that was blind to the ge-
notype of the mice. The genotyping was performed by PCR and Southern
analysis as detailed elsewhere (Orr-Urtreger et al., 1997). Cell cultures
were grown at 37 C and 5% CO2 in 25 cm
2 Falcon culture flasks using the
cell culture techniques optimized for mouse keratinocytes (Li et al., 1995;
Lee et al., 1997).
Immunocytochemical assay
Immunocytochemical analysis of nicotinergic effects on the expression of
differentiation markers was performed in situ in keratinocyte monolayers
as described previously (Grando et al., 1996). Stained monolayers were
examined microscopically and photographed. The numbers of cytokeratin
10–, transglutaminase-, involucrin-, and filaggrin-positive cells were
counted in at least three different microscopic fields at the magnification
 200, and the results were expressed as a percentage of the total cells. At
least 50 cell per each microscopic field were examined.
IF assay
The IF experiments with skin samples of  7
 /  and  7
 /  mice were per-
formed as detailed previously (Ndoye et al., 1998) using a computer-
assisted image analysis with a software package purchased from Scanalyt-
ics. The intensity of fluorescence was calculated pixel by pixel by dividing
the summation of the fluorescence intensity of all pixels by the area occu-
pied by the pixels (i.e., segment) and then subtracting the mean intensity of
fluorescence of a tissue-free segment (i.e., background). 
45Ca
2  influx assay
The experiments were performed in triplicate samples according to our
modification (Zia et al., 2000) of standard protocols (De Aizpurua et al.,
1988). Briefly, freshly isolated human neonatal foreskin keratinocytes were
counted with a hemocytometer and aliquoted in incubation buffers at a
concentration of 3   10
6 cells per 50  l per each Eppendorf tube. To mea-
sure basal and nicotinergic 
45Ca
2  influx, we used Krebs buffer (Sigma-
Aldrich) supplemented to contain 1.2 mM Ca
2  (”basal” buffer; pH 7.4).
Cell aliquots were resuspended in 300  l of basal buffer containing test
nicotinergic agents and 
45Ca
2  (specific activity 11.6 mCi/mmol; NEN) 1%
of total Ca
2 , and incubated for 1 min at 37 C. After washing three times by
centrifugation at 250 g for 1 min in a Beckman Coulter microcentrifuge in
ice-cold, radioactive calcium-free basal buffer, the cells were solubilized in
100  l Triton X-100 (Sigma-Aldrich), transferred into scintillation vials con-
taining 5.0 ml of a scintillation cocktail, and 
45Ca
2  taken up by the cells
was measured in a liquid scintillation counter. The amount of the ligand-
dependent 
45Ca
2  influx was expressed as a percentage of basal influx.
AsOs assay
The phosphorothioated and FITC-tagged AsOs and the phosphorothioated,
equally sized sense oligonucleotide (control) were commercially synthesized
by Operon. Following the protocol provided by the manufacturer, AsOs were
mixed with LipofectAMINE PLUS™ reagent (GIBCO BRL) and transfected into
second passage human foreskin keratinocytes grown to  50% confluence in
a standard 6-well tissue culture plate in 2.0 ml KGM. Each experimental cul-
ture received 20 nM of AsOs, and the control cultures received the same dose
of control (sense) oligonucleotide, diluted in KGM containing 1.2 mM Ca
2 , to
induce keratinocyte differentiation (Hennings and Holbrook, 1983).
 7 nAChR expression assays
To assess the effects of changes in extracellular Ca
2  concentrations on the
expression of keratinocyte  7 nAChRs, keratinocytes freshly isolated from
human neonatal foreskins were incubated for 0, 15, or 60 min in KGM
containing 1.2 mM Ca
2  in a humid 5% CO2 incubator after which the to-
Table III. The primary antibodies used in IF assays
Antibody specificity Isotype Host Concentration Epitope Reactivity
 g/ml
nAChRa3
a IgG Rabbit 1 CPLMAREDA Human and rodent
nAChRa5
a IgG Rabbit 1 CPVHIGNANK Human and rodent
nAChRa7
a IgG Rabbit 1 CFVEAVSKDFA Human and rodent
nAChRa9
b IgG Rabbit 1 CWHDAYLTWDRDQYDRLD and CNKADDESSEPVNTN Human and rodent
nAChRa10
c IgG Rabbit 1 RSHRAAQRRHEDWKR Human and rodent
p53
d IgG1 Rabbit 5 RHSVV Human and rodent
Cyclin D1
d IgG2 Rabbit 1 1–295 (whole protein) Human and rodent
PCNA
d IgG2 Rabbit 2.5 1–261 (whole protein) Human and rodent
Bcl-2
d IgG Rabbit 0.5 20–30 aa Human and rodent
Caspase 3
d IgG Rabbit 1 whole protein Human and rodent
CK 1
e IgG Rabbit 0.4 SSVKFCSTTYSGVTRC Human and rodent
CK 10
e IgG Rabbit 1 SGTGGGDQSSKGPNY Human and rodent
Filaggrin
e IgG Rabbit 0.5 DSQVHSGVQVEGRRGH Human and rodent
 -Actin
f IgG1 Mouse 0.2 PPIAALVIPSGSGL Human and rodent
Ki-67
g IgG1 Rabbit 1 2,597–2,896 Human and rodent
aResearch and Diagnostic Antibodies.
bRaised and characterized as detailed in Nguyen et al. (2000b).
cThe antiserum was raised against a 15 amino acid residue peptide (NH2-RSHRAAQRRHEDWKR-CONH2) identical to aa 404–417 of the predicted  10
protein (Elgoyhen et al., 2001). Preimmune serum was isolated. After this, a rabbit received injections of the peptide at 14-d intervals (total of five injec-
tions; Pineda Antikörper-Service). Standard procedures were used to further characterize the antibody.
dOncogene Research Products.
eBabCo.
fSigma-Aldrich.
gSanta Cruz Biotechnology, Inc. Nonneuronal function of  7 nicotinic receptor | Arredondo et al. 335
tal amount of  7 protein was measured by Western blotting (as described
below), and the membrane expression of this nAChR was evaluated us-
ing FITC-labeled  -BTX (Garcia-Borron et al., 1990). Briefly, quadrupli-
cate of experimental, i.e., 1.2 mM Ca
2 -treated, and control, i.e., 0.09
mM Ca
2 -treated, keratinocytes were resuspended in ice-cold PBS con-
taining 10  M FITC-labeled  -BTX (Molecular Probes, Inc.), incubated
for 1 h at 4 C, washed three times with PBS, loaded in standard 96-well
ELISA plates (Costar Corporation) at a concentration of 5   10
4/well, and
the fluorescence intensity ratio (at 494 nm excitation and 518-nm emis-
sion wavelengths) was measured using the Perkin Elmer HTS 7000 instru-
ment.
Western blot assay
Proteins were isolated from the phenol-ethanol supernatant of homogenized
human or murine keratinocytes or skin samples of neonatal mice by adding
1.5 ml of isopropyl alcohol per 1 ml of Trizol Reagent (GIBCO BRL) and an-
alyzed essentially as described in our protocol of a quantitative immunoblot
assay (Arredondo et al., 2001). The specificities and working concentrations
of primary antibodies used are listed in Table III. The membranes were de-
veloped using the ECL   Plus chemiluminescent detection system (Amer-
sham Biosciences). To visualize antibody binding, the membranes were
scanned with Storm™/FluorImager (Molecular Dynamics), and band inten-
sities were determined by area integration using ImageQuant software
(Molecular Dynamics). To normalize for the protein content, the house-
keeping protein actin was visualized in each sample with a mouse antiac-
tin monoclonal antibody (Sigma-Aldrich). The ratios obtained in three in-
dependent experiments were averaged to obtain the mean value (n   3).
The protein content ratio in every control (or  7
  / ) sample is always
equal to 1. The images represent typical results from a series of three inde-
pendent experiments.
RT-PCR assay
Total RNA was extracted from cultured keratinocytes and murine skin using
guanidinium thiocyanate phenol chloroform extraction procedure (Trizol Re-
agent; GIBCO BRL) as described elsewhere (Chomczynski and Sacchi, 1987).
1  g of dried, DNase-treated RNA was reverse transcribed in 20  l of RT-
PCR mix (50 mM Tris, pH 8.3, 6 mM MgCl2, 40 mM KCl, 25 mM dNTPs, 1
 g Oligo-dt [GIBCO BRL], 1 mM DTT, 1 U RNase inhibitor [Boehringer] and
10 U SuperScript II [GIBCO BRL]) at 42 C for 2 h. The PCR was performed in
a final volume of 50  l containing 1  l of the single strand cDNA product, 10
mM Tris-HCl (pH 9.0), 5 mM KCl, 5 mM MgCl2, 0.2 mM dATP, 0.2 mM
dCTP, 0.2 mM dGTP, 0.2 mM dTTP, and 2.5 U Taq DNA polymerase (Perkin
Elmer) and 20 pmol of each forward (5 ) and reverse (3 ) primers. To allow
a quantitative determination of relative gene expression levels (Arredondo
et al., 2001), the cDNA content of the samples was normalized, and the
linear range of amplification was determined for each primer set. For each
experiment, the housekeeping gene GAPDH was amplified with 20–30 cy-
cles to normalize the cDNA content of the samples. The amplification was
performed at 94 C (1 min), 60 C (2 min), and 72 C (3 min) for 24–30 cy-
cles. The specific primers used in this study are shown in Table II. The re-
ported ratios derived from the combination of the data obtained in three
independent experiments (n    3). The images represent typical results
from a series of three independent experiments. To standardize the analy-
sis, the gene expression ratio in the control (or  7
 / ) sample is always
equal to 1.
Statistics
The results of the quantitative assays were expressed as mean   SD. Signif-
icance was determined using Student’s t test.
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